...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: Biogen looks to FDA for approval of early Alzheimers drug.

Bear,

you don't give weight to the "rigorous academic requirements in confirming the primary endpoint" quote from Don McCaffrey in his Sept 30 conference call? 

I interpreted that to suggest that the trial failed on purely statistical grounds...i.e. more patient years would have got us to meeting endpoints.  How else can one interpret it?

Iconoclast

 

 

2
Oct 22, 2019 01:52PM
2
Oct 22, 2019 02:04PM
2
Oct 22, 2019 02:33PM
1
Oct 22, 2019 02:46PM
1
Oct 22, 2019 03:36PM
1
Oct 22, 2019 03:57PM
2
Oct 22, 2019 04:07PM
3
Oct 22, 2019 05:15PM
3
Oct 22, 2019 05:29PM
4
Oct 22, 2019 05:54PM
3
Oct 22, 2019 06:32PM
4
Oct 22, 2019 06:37PM
4
Oct 22, 2019 07:23PM
5
Oct 22, 2019 09:34PM
9
Oct 22, 2019 11:59PM
3
Oct 23, 2019 01:53AM
2
Oct 23, 2019 07:17AM
4
Oct 23, 2019 08:02AM
1
Oct 23, 2019 08:19AM
2
Oct 23, 2019 08:50AM
1
Oct 23, 2019 09:23AM
2
Oct 23, 2019 10:44AM
1
Oct 23, 2019 12:40PM
1
Oct 23, 2019 12:41PM
3
Oct 23, 2019 12:49PM
2
Oct 23, 2019 12:59PM
4
Oct 23, 2019 01:03PM
Share
New Message
Please login to post a reply